22 Myalgic Encephalomyelitis Clinical Trials in San Antonio, TX (2026)

Q: How do I join a clinical trial in San Antonio?

Browse available studies, click one that interests you, and complete the free eligibility form. A study coordinator at the San Antonio research site will contact you.

Recruiting Myalgic Encephalomyelitis Studies in San Antonio

NCT05458219Recruiting

A First-in-human Study of IBI343 in Subjects With Locally Advanced Unresectable or Metastatic Solid Tumors

This is a Phase Ia/Ib, multicenter, open-label, first-in-human study to evaluate the safety, tolerability, PK, and efficacy of IBI343 in participants with locally advanced unresectable or metastatic s...

San Antonio, TXPHASE1470 participantsInnovent Biologics (Suzhou) Co. Ltd.

View Study Details

NCT04665206Recruiting

Study to Evaluate VT3989 in Patients With Metastatic Solid Tumors

This is an open-label, dose escalation and expansion study to evaluate the safety, tolerability, PK, and biological activity of VT3989 administered, alone or in combination, once daily in patients wit...

San Antonio, TXPHASE1434 participantsVivace Therapeutics, Inc

View Study Details

NCT07122700Recruiting

Evaluation of Non-Invasive Tests for Metabolic Liver Disease

The Non-Invasive Biomarkers for Metabolic Liver Disease (NIMBLE) study is a comprehensive, multi-year collaborative effort to standardize, validate and advance the regulatory qualification of blood- a...

San Antonio, TX400 participantsFoundation for the National Institutes of Health

View Study Details

NCT06752681Recruiting

To Evaluate the Safety, Tolerability, Pharmacokinetics and Antitumor Activity of DAY301 in Participants With Locally Advanced or Metastatic Solid Tumors

This is a Phase 1a/1b, open-label, dose escalation and expansion study to evaluate the safety and anti-tumor activity of DAY301, a PTK7-directed antibody-drug conjugate in participants with advanced o...

San Antonio, TXPHASE1254 participantsDay One Biopharmaceuticals, Inc.

View Study Details

NCT06234397Recruiting

Dose Escalation and Expansion Study of BH3120 Alone or With Pembrolizuamb in Advanced or Metastatic Solid Tumors

This is a First-in-Human, Phase 1, Dose-Escalation and Dose-Expansion study of BH3120, as a single agent and in combination with pembrolizumab, to assess safety, tolerability, MTD, RP2D, PK, and effic...

San Antonio, TXPHASE1245 participantsHanmi Pharmaceutical Company Limited

View Study Details

NCT07141706Recruiting

A Study of DB-1317 in Selected Advanced/Metastatic Solid Tumors

This is a multicenter, open-label, multiple-dose, FIH Phase 1a/1b study. Phase 1a adopts an accelerated titration design and a BOIN design to identify the MTD or MAD of DB-1317; Phase 1b includes up t...

San Antonio, TXPHASE1233 participantsDualityBio Inc.

View Study Details

NCT07527910Recruiting

A Phase 2a Study of ALN-PNP With and Without a GLP1R Agonist in Adult Patients With Homozygous PNPLA3-Related MASLD

This study will test a study drug called ALN-PNP with and without another drug that is used for controlling blood sugar, appetite, and weight (for example, tirzepatide), to see if it can help treat MA...

San Antonio, TXPHASE2204 participantsRegeneron Pharmaceuticals

View Study Details

NCT07021898Recruiting

A Study of ERAS-4001 in Patients With Advanced or Metastatic Solid Tumors.

The main purpose of the study is to assess whether the study drug, ERAS-4001, is safe and tolerable when administered to patients with advanced or metastatic solid tumors with certain KRAS mutations. ...

San Antonio, TXPHASE1200 participantsErasca, Inc.

View Study Details

NCT05592678Recruiting

δ in Dementia Clinical Trials

The goal of this clinical trial is to demonstrate potential improvements in clinical trial methods relating to dementia and cognitive decline. The main questions it aims to answer are: * Can an inter...

San Antonio, TXNA200 participantsThe University of Texas Health Science Center at San Antonio

View Study Details

NCT05267626Recruiting

Study of AU-007, A Monoclonal Antibody That Binds to IL-2 and Inhibits IL-2Rα Binding, in Patients With Unresectable Locally Advanced or Metastatic Cancer

This is a first in human, open-label, multi-center Phase 1 / 2 study to evaluate the safety, tolerability, and initial efficacy of AU-007 in patients with advanced solid tumors. AU-007 will be adminis...

San Antonio, TXPHASE1159 participantsAulos Bioscience, Inc.

View Study Details

NCT06333990Recruiting

Quetiapine to Reduce Post Concussive Syndrome After Mild Traumatic Brain Injury (mTBI)

A two site, 2-arm, Phase III randomized pragmatic clinical trial evaluating the effectiveness of quetiapine monotherapy in comparison to Treatment As Usual (TAU) medication management for symptoms exp...

San Antonio, TXPHASE3146 participantsFoundation for Advancing Veterans' Health Research

View Study Details

NCT06240728Recruiting

A Study of NPX887 for Participants With Solid Tumors Known to Express B7-H7/HHLA2

NPX887 is a human, antagonistic immunoglobulin G1 (IgG1) monoclonal antibody targeting B7-H7 (HHLA2) that may potentiate an anti-tumor immune response. The goal of this first-in-human study is to lear...

San Antonio, TXPHASE1144 participantsNextPoint Therapeutics, Inc.

View Study Details

NCT07103018Recruiting

A Clinical Study of KTX-2001 in Subjects With Metastatic Castration-Resistant Prostate Cancer (STRIKE-001)

Study K36-MCRPC-001 is the first in human clinical trial testing KTX-2001 alone and with darolutamide in men with metastatic castration-resistant prostate cancer. The study aims to assess whether the ...

San Antonio, TXPHASE1144 participantsK36 Therapeutics, Inc.

View Study Details

NCT06067841Recruiting

A Study to Assess BMS-986460 in Participants With Metastatic Castration-resistant Prostate Cancer

The purpose of this study is to assess the safety, tolerability, and preliminary efficacy of BMS-986460 in men with Metastatic Castration-resistant Prostate Cancer....

San Antonio, TXPHASE1140 participantsBristol-Myers Squibb

View Study Details

NCT07535112Recruiting

A Study to Learn More About How Safe BAY 3771249 is and How Well it Works in People With Advanced or Metastatic Colorectal Cancer That Has a KRAS G12D Mutation

Researchers are looking for a better way to treat people who have advanced or metastatic colorectal cancer (CRC) with a specific mutation, the G12D mutation, in a protein called KRAS. Colorectal canc...

San Antonio, TXPHASE1130 participantsBayer

View Study Details

NCT06550284Recruiting

Small Nerve Fiber Activity in Patients with Carpal Tunnel Syndrome Assessed Via Quantitative Sensory Testing

The diagnosis of carpal tunnel syndrome (CTS) is typically based on clinical findings and confirmatory electrodiagnostic testing. However, electrodiagnostic testing can only assess large A-alpha and A...

San Antonio, TXNA48 participantsBrooke Army Medical Center

View Study Details

NCT04789044Recruiting

Evaluating the Safety and Efficacy of Polyethylene Glycol (PEG) Mediated Fusion (PEG Fusion)

The overall objective of this study is to determine the safety of PEG fusion when used with primary repair or reconstruction in patients with an acute upper extremity peripheral nerve injury. PEG is s...

San Antonio, TXPHASE240 participantsMajor Extremity Trauma Research Consortium

View Study Details

NCT06442436Recruiting

A Study of Nemtabrutinib in Participants With Moderate Hepatic Impairment (MK-1026-015)

The purpose of this study is to compare the plasma pharmacokinetics (PK) of nemtabrutinib (MK-1026) following a single oral dose of nemtabrutinib in participants with moderate hepatic impairment to th...

San Antonio, TXPHASE132 participantsMerck Sharp & Dohme LLC

View Study Details

NCT07098806Recruiting

Multiple Dose Intraventricular Administration of Rhenium-186 NanoLiposome for Leptomeningeal Metastases

This is an open-label, multicenter, Phase 1 study to determine the safety and efficacy of multiple doses at defined intervals of rhenium (186Re) obisbemeda (rhenium-186 nanoliposome, 186RNL) administe...

San Antonio, TXPHASE124 participantsPlus Therapeutics

View Study Details

NCT06801639Recruiting

Advancing Alzheimer's Care: Home-based tDCS for Affective Symptoms

Participants will be asked to participate in this research study of a device that creates transcranial direct current stimulation (tDCS). The researchers hope to learn if 30 minute sessions of transc...

San Antonio, TXNA24 participantsThe University of Texas Health Science Center at San Antonio

View Study Details

NCT05789056Recruiting

Open Label, Safety and Efficacy Study of QRX003 Lotion in Subjects With Netherton Syndrome

To assess the safety, tolerability, and efficacy of QRX003 lotion (4%) when added to standard of care treatment regimen, including systemic therapy in subjects with Netherton syndrome...

San Antonio, TXPHASE220 participantsQuoin Pharmaceuticals

View Study Details

NCT07538583Recruiting

Phase 2/3 Clinical Study of QRX003 Lotion in Subjects With Netherton Syndrome

This is a multicenter, open-label study to evaluate the safety, tolerability, and efficacy of 4% QRX003 lotion applied twice daily (BID) for 12 weeks to Netherton syndrome (NS) diseased skin in all af...

San Antonio, TXPHASE216 participantsQuoin Pharmaceuticals

View Study Details

About Myalgic Encephalomyelitis Clinical Trials in San Antonio

Myalgic encephalomyelitis (ME/CFS) is a complex, chronic illness characterized by profound fatigue, post-exertional malaise, cognitive impairment, and sleep dysfunction. It affects millions worldwide and has no definitive diagnostic test or cure. Research is exploring immune, metabolic, and neurological mechanisms.

There are currently 22 myalgic encephalomyelitis clinical trials recruiting participants in San Antonio, TX. These studies are seeking a combined 3,707 participants. Research is being sponsored by Innovent Biologics (Suzhou) Co. Ltd., Vivace Therapeutics, Inc, Foundation for the National Institutes of Health and 17 other organizations. Clinical trial participation is free and participants receive study-related medical care at no cost.

Myalgic Encephalomyelitis Clinical Trials in San Antonio — FAQ

Are there myalgic encephalomyelitis clinical trials in San Antonio?

Yes, there are 22 myalgic encephalomyelitis clinical trials currently recruiting in San Antonio, TX. Browse the studies on this page to find one that fits.

How do I join a clinical trial in San Antonio?

Browse the studies listed above, click one that interests you, and complete the free eligibility form. A study coordinator at the San Antonio research site will contact you about next steps.

Are clinical trials in San Antonio free?

Yes, clinical trial participation is always free. Study-related treatment, medical tests, and doctor visits are provided at no cost. Many San Antonio studies also compensate for your time and travel.

What myalgic encephalomyelitis treatments are being tested?

The 22 active trials in San Antonio are testing new therapies including novel drugs, biologics, and treatment approaches for myalgic encephalomyelitis.

Data updated July 22, 2026 from ClinicalTrials.gov